Every one of those 1 sits in a single category, medical-devices. Mesa Laboratories, Inc. is most often covered alongside Biopharmaceutical Development, which appears in 1 of these 1 story. Mesa Laboratories, Inc. appears in 1 tracked Healthcare story from August 11, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Mesa Laboratories, Inc.
Every one of those 1 sits in a single category, medical-devices. Mesa Laboratories, Inc. is most often covered alongside Biopharmaceutical Development, which appears in 1 of these 1 story. Mesa Laboratories, Inc. appears in 1 tracked Healthcare story from August 11, 2026. The tracked stories average 3 original sources each.
Stories tracked
1
Sources per story
3
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 10 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Mesa Laboratories, Inc.. Shared-story counts are live from our verified record — not editorial picks.
Mesa Laboratories' Sterilization and Disinfection Control business faces fulfillment bottlenecks that are restraining growth in a $60.1M revenue quarter. New CEO Siddhartha Kadia vows to fix execution problems in a unit critical for hospital sterilization monitoring and infection prevention.